Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Jun 30.
Published in final edited form as: J Proteome Res. 2025 Sep 12;24(10):5116–5126. doi: 10.1021/acs.jproteome.5c00469

Improving proteomic dynamic range with Multiple Accumulation Precursor Mass Spectrometry (MAP-MS)

Teeradon Phlairaharn 1,2, Ariana E Shannon 1, Xinlei Zeng 3, Dong-Jiunn Jeffery Truong 4, Erwin M Schoof 5, Zilu Ye 3, Brian C Searle 1,*
PMCID: PMC13312262  NIHMSID: NIHMS2185575  PMID: 40940309

Abstract

Orbitrap (OT) -based mass spectrometer platforms are a gold standard in high-resolution mass spectrometry, where their primary disadvantage is slower-scanning speed in comparison to time-of-flight or linear ion trap mass analyzers. In this study, we utilize long OT transients to extend the precursor dynamic range by modifying the selected ion monitoring method to multiplex several precursor m/z ranges into a single scan, which we call “Multiple Accumulation Precursor Mass Spectrometry” (MAP-MS). Our approach requires no software or hardware modifications and hides the additional ion accumulation steps during the time it takes to make other Orbitrap measurements, producing precursor spectra with nearly 2× dynamic range and essentially no consequences. We collected data using both data-dependent acquisition (DDA) and data-independent acquisition (DIA) methods to evaluate a range of approaches. With DDA, MAP-MS precursor quantification improves with higher quality measurements. At the same time, DIA detection is enhanced by up to 11% when combining precursor and tandem mass spectra for peptide detection.

Keywords: peptide identification optimization, peptide quantification optimization, orbitrap mass analyzer, multiplexing, mass spectrometry, data-dependent acquisition, data-independent acquisition

Graphical Abstract

graphic file with name nihms-2185575-f0001.jpg

INTRODUCTION:

Bottom-up proteomics using mass spectrometry (MS) is a powerful technique for global proteome profiling, where instruments typically record two types of scans.1 MS1 spectra measure intact peptide m/z ratios to provide an overview of the molecular species present in the sample at a given retention time. MS/MS spectra measure peptide fragment ions, offering detailed structural and sequence information from the m/z ratios of generated fragments. In DDA, precursors with the highest intensities are targeted for MS/MS analysis,2 and quantification is typically performed using MS1 signals. In contrast, DIA3,4 allows for quantification using either MS1 or MS/MS signals,5 and identification in bottom-up proteomics typically relies on a combination of MS1 and MS/MS signals.6

One challenge in bottom-up proteomics is the dynamic range limitations of mass spectrometers, where high-abundance precursor species can saturate the ion capacity. This creates a bottleneck in the DDA quantification analysis when high-abundance ions saturate (e.g., the C-Trap), preventing low-abundance species from accumulating sufficient copies for detection. Fundamentally, the difference between standard (non-trapping) quadrupole ToF mass spectrometers (QToF-MS) and trapping devices like Orbitraps™ (OT) or linear ion traps (LIT) is how long ions spend in proximity inside the instrument. For QToF-MS, which processes a continuous flow of ions, the ions are constantly moving through the instrument, meaning their interaction with any part of the mass spectrometer is usually less than 1 millisecond (ms). In contrast, traps allow ions to accumulate inside the instrument for a much longer duration before being analyzed, which is fundamentally different from the more transient behavior seen in non-trapping quadrupoles or ToF systems.

With OTs, LITs, and other instruments that trap ions, dynamic range limitations can be significant. Automatic gain control (AGC) and other ion injection regulation systems help manage ion capacity to prevent ion accumulation and mitigate dynamic range limitations that can impact data quality. However, high-abundance species can become dominant in the trap, resulting in a limited dynamic range within a single scan. This is particularly noticeable when there is a large disparity in ion abundances, which can overwhelm the system's capacity to measure both low and high-abundant species within the same scan, even causing space charging effects and ion coalescence in some Orbitrap spectra. In summary, the fundamental difference between non-trapping systems (quadrupole and ToF) and trapping systems (OT and LIT) lies in how long ions remain inside the instrument, which influences their space charge limitations and the overall ability of the system to handle a wide dynamic range of signals.

Meier et al. established an acquisition method known as 'BoxCar' using the Q Exactive™ HF hybrid quadrupole-Orbitrap mass spectrometer to improve intrascan dynamic range at the expense of not collecting MS/MS spectra.7 This method lengthens cycle time by filling multiple m/z ranges with longer ion injection time (IIT), allowing low-abundance species to be detected in precursor scans and performing accurate mass and time (AMT) analysis on the MS1 level. Newer approaches mix BoxCar measurements with some MS/MS acquisition by decreasing MS1 resolution and ion accumulation time.8–10 When applying this method, finding a balance between reasonable cycle time, the number of MS/MS scans, and the selectivity of precursor scans is crucial.

Here, we introduce a multiplexed acquisition strategy termed “Multiple Accumulation Precursor Mass Spectrometry” (MAP-MS), which extends the dynamic range and quality of MS1 by increasing the efficiency of parallelized transient recording and ion injections to accumulate multiple packets of ions across several precursor mass ranges. MAP-MS borrows conceptually from variable isolation MSX,11 but is applied to precursor isolations rather than DIA windows. In this study, we demonstrate that MAP-MS DIA analysis enhances true identification by 11%, based on the analysis of 125 ng of HeLa peptide digest acquired through MAP-MS, when searching in library-free mode. Additionally, quantification in DDA analysis is enhanced, as evidenced by the improved coefficient of variation (CV) values obtained when quantification is performed at the precursor level.

EXPERIMENTAL SECTION:

Sample preparation and LC mass spectrometry.

Pierce HeLa Protein Digest Standard (Thermo Fisher Scientific, catalog number: 88328) was used to perform LC-MSMS analysis. The HeLa protein digest was separated and analyzed using an Aurora Ultimate TS 25×75 C18 UHPLC column (IonOpticks) in a 1-column setup with a 1-hour gradient at 250 nL/min and an EASY-nLC 1200 (Thermo Fisher Scientific). Mobile phases A and B were 0.1% formic acid in water and 0.1% in Acetonitrile. The LC system was directly coupled to an Orbitrap Exploris 480 mass spectrometer (Thermo Fisher Scientific, Instrument ID: MA10516) using an EasySpray ion source. The instrument operated with software version 4.1–4.1.292.16/4.1.335.19. We used 125 ng injections for all measurements.

Standard DDA data acquisition.

The scan sequence began with a target selective ion monitoring (tSIM) scan as a precursor ion spectrum on OT at 60k resolution, covering a scan range of 350.4 – 1200.8 m/z, a normalized AGC target of either 100% (1e6 ions) or 300% (3e6 ions), and a maximum injection time (IIT) of 24 ms, with the RF lens set to 40%. Precursors for MS/MS analysis were selected in a Top20 fashion, and only charge states 2–6 were included. For MS/MS analysis, precursors were isolated using a 2 m/z isolation window and fragmented using HCD with 27% normalized collision energy (NCE). The normalized AGC target was set to 50% (5e4 ions), and the maximum IIT was set to “Auto”. Slightly wider 2 m/z isolation windows were chosen to take advantage of chimeric peptide detection strategies.12

Standard DIA data acquisition.

The scan sequence began with a tSIM scan as a precursor ion spectrum on OT at 60k resolution, covering a scan range of 390 – 1010 m/z, a normalized AGC target of either 100% (1e6 ions) or 300% (3e6 ions), and a maximum IIT of 60 ms, with the RF lens set to 40%. The MS/MS analysis used HCD targeted MS2 (tMS2) measurements (27% NCE), where the precursor isolation range was defined in a mass list table from 400 to 1000 m/z with 16 m/z staggered windows13 to achieve selectivity of 8 m/z (Sup. Tab. S1). The normalized AGC target was set to 1000% (1e6 ions), and the maximum IIT to 60 ms. Mass list tables for tSIM and tMS2 in this study were generated using the Encyclopedia software package.14

MAP-MS DDA data acquisition.

MAP-MS DDA used the same acquisition strategy as Standard DDA, except with a different MS1 acquisition approach. The MS1 sequence began with six tSIM accumulations measured in a single spectrum configured at 60k resolution across a scan range of 350.4 – 1200.8 m/z. The isolation windows were as follows: 126 m/z centered at 413.4378 m/z, 90 m/z centered at 521.4869 m/z, 89 m/z centered at 611.0276 m/z, 100 m/z centered at 705.5706 m/z, 135.1 m/z centered at 823.124 m/z, and 310 m/z centered at 1045.7252 m/z (Sup. Tab. S2). These isolation widths were determined based on the distribution of peptide precursor m/zs in the Pan-Human dataset.15 The normalized AGC target was 1000% (1e6 ions), with a maximum IIT of 4 ms per window (24 ms total max IIT) and an RF lens configuration at 40%. MS/MS were selected and measured in the same way as for Standard DDA.

MAP-MS DIA data acquisition.

Again, MAP-MS DIA used the same acquisition strategy as Standard DIA, except for a different MS1 approach. Here, the scan sequence began with six tSIM scans as precursor ion spectra on OT at 60k resolution, with a scan range of 390 – 1010 m/z. The isolation windows were as follows: isolation window 91 m/z centered at 445.9526 m/z, 78 m/z centered at 530.491 m/z, 78 m/z centered at 608.5265 m/z, 84 m/z centered at 689.5634 m/z, 106 m/z centered at 784.6065 m/z, and 163.1 m/z centered at 919.1677 m/z (Sup. Tab. S3), The normalized AGC target was 1000% (1e6 ions), with a maximum IIT of 10 ms per window (60 ms total max IIT) and an RF lens configuration at 40%. MS/MS were measured in the same way as for standard DIA.

Chromatogram library generation.

Gas-phase fractionation16,17 (GPF) was performed to generate a chromatographically matched DIA-based library14 for this study. For this, we injected 125 ng HeLa tryptic digest six times covering different 100 m/z ranges between 400 – 1000 m/z (400 – 500 m/z, 500 – 600 m/z, 600 – 700 m/z, 700 – 800 m/z, 800 – 900 m/z, and 900 – 1000 m/z) using the same LC methods for single-shot analysis. For standard DIA, the scan sequence began with a tSIM scan acquired as a precursor ion spectrum on the OT at 60k resolution, using a normalized AGC target of 1000% (1e6 ions), a maximum IIT of 10 ms, an RF lens setting of 40%, and no multiplexed ions. MS/MS analysis parameters were identical to those used in the “Standard DIA acquisition.” The isolation windows were configured as detailed in the Supporting Information (Sup. Tabs. S5, S7, S9, S11, S13, and S15). For MAP-MS DIA, all parameters for MS and MS/MS analysis were identical to those used in standard DIA for GPF, except that the number of multiplexed ions was set to six. The isolation windows were configured as detailed in the Supporting Information (Sup. Tabs. S4, S6, S8, S10, S12, and S14).

Precursor comparison data acquisition.

We implemented a single method to characterize multiple types of precursor measurements simultaneously. This method collected seven different types of precursor spectra, each roughly covering 400–1000 m/z in succession. The first MS1 approach was modeled after BoxCar,7 measuring six isolation windows in six MS1 spectra (36 distinct m/z windows, detailed in Sup. Tab. S16). Each precursor ion spectrum was acquired using a SIM scan on the Orbitrap at 30k resolution, with a normalized AGC target of 1000%, a maximum IIT of 10 ms, an RF lens setting of 40%, and multiplexed ions enabled to cover distinct mass ranges. MS1 approaches 2, 3, 4, and 5 are different approaches to MAP-MS using alternate windowing schemes with 20 windows (Max IIT=1.25 ms), 12 windows, (Max IIT=2 ms), 6 windows (Max IIT=4 ms), and 3 windows (Max IIT=8 ms), with window schemes detailed in Sup. Tabs. S3, S17, S18, and S19. The Max IIT settings were chosen to keep the summed ion injection times within a total of 20–25 ms. The sixth MS1 approach used the tSIM configured for 1000% AGC (1e6 ions) while the seventh MS1 approach used the standard MS1 configuration for 100% AGC (1e6 ions). No MS/MS were collected in this acquisition method.

Bioinformatics.

DDA raw files were processed using FragPipe18 version 22.0 for all searches and its built-in search engine MSFragger.19 For Thermo data, raw files were converted to mzML files by ProteoWizard. Files from different samples were processed separately. The data type was set to “DDA”, and the “default” workflow was used with the DDA+ configuration.20 Files from the same sample were given the same “Experiment” name and “Bioreplicate” number. The Uniprot with “UP000005640_9606” entries released in 2022 was specified as a protein sequence database. IonQuant was used for protein-level quantification, and the MaxLFQ approach was set. All other options were kept as default. Spectronaut (version 19.0.240604.62635) (Biognosys) was used to process DIA data for directDIA via a spectrum-centric approach21 and for library-based searching using the GPF library. False-discovery rates (FDRs) for peptide spectral matches (PSMs), peptides, and proteins were set at 1%. Trypsin/P was chosen to ensure enzyme specificity. The peptide length in the search space ranged from seven to fifty-two amino acids, with a maximum allowance of two missed cleavages. Cysteine carbamidomethylation was specified as a fixed modification, while N-terminal acetylation and methionine oxidation were selected as variable modifications. Default settings were applied for all other parameters.

Statistics.

Output tables from FragPipe and Spectronaut were imported into RStudio (Version 2024.04.1). For DDA analysis, all detected peptides and proteins are retained initially. Subsequently, peptides and protein groups with zero intensity values are filtered out. Only peptides and proteins in at least two of three replicates were retained for DIA analysis. Afterward, peptides and protein groups with a quantity of one and/or containing at least one NA value are filtered out.

RESULTS AND DISCUSSION:

Leveraging Long Orbitrap Transients to Enable MAP-MS

Ion accumulation and ion measurement happen in parallel in OT instruments. However, the time required for those activities varies depending on the type of measurement. With standard OT MS1 measurements, ions are accumulated quickly (typically 1 – 2 ms) across a single, wide precursor isolation range (Fig. 1A), but in parallel, 15k resolution DDA measurements take approximately 68 ms (derived from a 64 ms transient and a 4 ms interval between transients), resulting in a scan rate of about 14.7 Hz. As such, while OT instruments parallelize ion accumulation during data acquisition, for MS1 measurements, the instrument typically wastes most of the parallel time.

Figure 1:

Figure 1:

(A) Standard MS/MS acquisition scheme. The typical ion accumulation time for the precursor ion scan (MS1) is less than 2 ms despite the available time remaining from the preceding MS/MS scan cycle. (B) MAP-MS acquisition scheme using multiplexed tSIMs. The precursor ion scan was acquired in tSIM mode, with the 400–1,000 m/z range divided into six subranges (MPx 1 - MPx 6). The maximum IIT for each subrange was set to 10 ms to utilize the remaining time from the preceding MS/MS scan cycle. (C) An example precursor scan acquired using the standard acquisition method. (D) Matched precursor scan acquired using MAP-MS. In Figs. 1C and 1D, the 750–800 m/z region of the full scan is blown up for visualization. With the MAP-MS acquisition method, low-abundance peaks in this region become detectable, whereas they are missed using the standard method due to limitations in dynamic range. In the standard acquisition method, ions from 400–1,000 m/z are accumulated together within a fixed IIT. In contrast, MAP-MS divides the range into narrower windows (732–838 m/z and 838–1,001 m/z), enabling more efficient ion accumulation and enhanced detection of low-abundance signals. (E) A 6× MS1 BoxCar acquisition scheme. The schematic illustrates the BoxCar acquisition method applied across six segmented regions spanning 400–1,000 m/z. Following the acquisition of BoxCar 1, the adjacent region is sequentially acquired in subsequent scans, continuing this pattern to generate a precursor-only Thermo RAW file. (F) Individual peaks acquired in 6× MS1s using the BoxCar method. As a result of the six BoxCar precursor scans, all detectable peaks are shown as individual dots, with intensity on the plot-specific y-axes and the corresponding m/z value on the plot-consistent x-axis. The colors in each panel correspond to the defined BoxCar regions shown in Fig. 1E. (G) Combined 6× MS1s using the BoxCar method. On the left, the six precursor scans from Fig. 1F combined illustrate all detectable peaks using BoxCar scaled to the same y-axis (intensity), where each dot represents a peak’s intensity and its corresponding m/z value. On the right, the same data from the combined BoxCar scans are displayed as a spectrum with the same 750–800 m/z region blown up for visualization, highlighting the dynamic range similarity between MAP-MS and BoxCar. The spectra in Figures 1C, 1D, 1F, and 1G were acquired immediately adjacent to each other in the same injection to avoid issues with chromatography.

MAP-MS multiplexes precursor ions into multiple precursor m/z range packets using a scheme analogous to MSX11 (Fig. 1B). This approach is similar to BoxCar,7 where several ultra-high resolution MS1 spectra are accumulated for very long periods (typically 240 ms) in narrow precursor m/z ranges, resulting in high-quality precursor scans. The long MS1 durations mean that there is no time to collect fragmentation data; as such, peptides are identified using accurate mass and time matching (AMT).22 In contrast, MAP-MS hides ion accumulation inside the time used to record other OT transients, allowing extra accumulation over a relatively long period. In addition, MAP-MS only acquires a single MS1 per cycle, resulting in essentially no change in the number of acquired spectra and requiring no software or hardware modifications, making it essentially consequence-free.

As we present it, MAP-MS is designed to perform six injections for six precursor ion packets across different mass ranges (Sup. Fig. 1). To effectively hide MAP-MS ion accumulation, tuning the accumulation time is essential. In a modern high-field Orbitrap, roughly 58 ms are available within the time it takes to make 15k resolution DDA measurements. Since 6 ms are required for electronics stabilization per injection, this leaves 22 ms for collecting ions from all six windows in each MS1. With MAP-MS, we accumulate ions from higher m/z windows first, which helps prevent the loss of high m/z ions that are more weakly confined by the RF pseudopotential in the C-Trap or ion routing multipole (IRM) and are thus more susceptible to space-charging effects. If accumulation were to begin with low m/z ions, these more tightly confined ions could crowd the trap, causing high m/z ions to be lost when the trap becomes overfilled.

To illustrate the effect of MAP-MS in comparison to a standard MS1 scan, we compared paired spectra acquired back-to-back. In the standard acquisition method, the precursor m/z range from 400 to 1000 m/z is isolated as a single group. High-abundance precursors can fill the C-trap's capacity, leading to the loss of low-abundance precursors, particularly in the higher m/z regions, for example, 750 to 800 m/z (Fig. 1C). In contrast, MAP-MS fills these regions separately from the high-abundance precursors, producing MS1s with higher dynamic range and detects twice the number of ions with distinct m/zs, even though the scanning times for both methods are identical (Fig. 1D). To further illustrate the MAP-MS method, we compared MAP-MS to an “ideal” BoxCar-like method collecting six spectra containing six sub-precursor m/z ranges (6×6) from 400 to 1000 m/z for a total of 36 distinct ion isolations (Fig. 1E). When the individual accumulations (Fig. 1F) are combined, the resulting spectrum produces a very high-quality MS1 (Fig. 1G), confirming the level of detailed signal in the MAP-MS spectrum. While the six-spectrum BoxCar approach measures more precursor peaks, the significant reduction in scanning time (a factor of six) gives MAP-MS a notable advantage in overall instrument utilization. Essentially, MAP-MS produces precursor spectra that are partway between BoxCar MS1s and standard MS1s without the additional measurement cost of BoxCar methods.

Using a method that contained only precursor measurements, we directly compared standard MS1 acquisitions to MAP-MS approaches with 1× (a normal tSIM), 3×, 6×, 12×, and 20× windows, as well as the 6×6 BoxCar approach applied to a HeLa proteome. Aside from the “ideal” 6×6 BoxCar benchmark, the other scan types were designed to achieve a maximum IIT of 24–25 ms, matching the 22-ms injection window of 15k resolution DDA MS2s. First, we calculated the total peak count in each precursor ion scan across seven different acquisition setups (Fig. 2A). Unsurprisingly, when configured for the same AGC, MS1 and targeted tSIM spectra produced nearly identical results. We observed that all MAP-MS methods measured more precursor peaks than the standard MS1 methods but fewer than 6×6 BoxCar, where MAP-MS with six isolations was the best compromise between the number of isolations and the maximum IIT per isolation (1.9× more ions than standard MS1s). The maximum over the median intensity value is a measure of signal-to-noise, and again, while all MAP-MS approaches produced better spectra than the standard MS1 methods, MAP-MS with six isolations produced the highest signal-to-noise of the single spectrum approaches (Fig. 2B). Actual ion injection times show that MAP-MS with 3× ion packets sometimes exits early, MAP-MS with 6× or more ion packets always maximizes the total ion injection time available (Fig. 2C). For comparison, the 6×6 BoxCar method required 15× the total ion injection time (spread across 6× spectra) that was available to the single spectrum approaches. Based on our results, we conclude that MAP-MS with 6 ion packets, including the electronic stabilization time, represents an optimized setup that can effectively replace the standard acquisition method.

Figure 2:

Figure 2:

(A) The distribution of total peak counts from precursor ion scans obtained using seven different acquisition methods. (B) Log-scaled distribution of intensity spread (max/median) from precursor spectra as a measure of the dynamic range. Violin plots indicate the medians as a dot and boxes show the interquartile range. (C) Actual ion injection times per precursor spectrum as a measure of accumulation time utilization. Each dot represents the IIT from an individual precursor ion scan for each method, with the median IIT for each method indicated by a black dot.

Focusing on MAP-MS with six ion packets, we tested its usage for MS1 measurements in both DDA and DIA acquisition. First, we verified that using MAP-MS did not dramatically change the number of acquired MS1s or MS2s relative to using standard MS1s acquired with a 1e6 AGC target (Table 1), confirming that the technique did not have significant consequences with regard to the total scan time. Next, we confirmed that it did not change the distribution of intensities (Fig. 3A). MAP-MS increases the total number of peaks relative to standard MS1s acquired with either 1e6 or 3e6 AGC targets, and these new peaks fill out the distribution of low intensity measurements. Standard MS1 (1e6) appears to have slightly more peaks with high abundance, but this is due to the mild increase in the total number of MS1s acquired versus MAP-MS, and when the AGC target is set to 3e6 (approximately 2%).

Table 1:

Summary of the number of MS1 and MS2 scans for each acquisition method, along with the corresponding normalized AGC targets as both number of charges and target percentages in parentheses. Each measurement was acquired in three replicates.

Acquisition approach Normalized AGC target Average Number of MS1 scans Average Number of MS2 scans
Standard DDA 1e6 (100%) 13436 129877
Standard DDA 3e6 (300%) 10825 125718
MAP-MS DDA 1e6 (1000%) 13147 124726
Standard DIA 1e6 (100%) 2243 85222
Standard DIA 3e6 (300%) 2213 84052
MAP-MS DIA 1e6 (1000%) 2204 83720

Figure 3:

Figure 3:

(A) Comparison of peak counts and intensity distributions across three acquisition methods. MAP-MS demonstrates improved detection of low-intensity peaks. (B) Scaling of the normalized ion injection time during the elution of an example 410.7 m/z peak. MPx ion injection times (solid lines) use the left y-axis, while the XIC of peak 410.7 m/z (dashed line) uses the right intensity y-axis. At the time point when the peak at m/z 410.7 eluted, the IIT for MPx 6 (covering the 400–491 m/z range) was automatically adjusted by the mass spectrometer, allowing the remaining time to be allocated to other regions containing lower-abundance peaks. The left y-axis is in log scale to more clearly visualize the dynamic range changes in IIT.

A critical aspect of MAP-MS is that the AGC target must be applied to each window separately, such that different ion packets get different ion injection times. To demonstrate this, we mapped ion injection time across time for select peaks. We found that the set AGC target dynamically scales the IIT across specific precursor windows in response to the elution of dominant species. Surrounding the example precursor 410.7 m/z shown in Fig. 3B, the total maximum IIT is set to 60 ms, where on average, each window is given 10 ms. However, while the 410.7 m/z peak elutes, the actual IIT for MPx 6 (covering the 400–491 m/z range) automatically adjusts to avoid saturating the number of charges and allows the trap to be filled with ions from other windows. This enabled redistribution of IIT to other MPx regions, enhancing the likelihood of detecting low-abundance ions by allowing extended ion accumulation. Multiplexing of MPx regions occurs within a single spectrum and is implemented at the hardware level. This is a key advantage over alternative strategies that rely on software-level merging of multiple spectra with interleaved windows (such as BoxCar), which can result in complex quantification errors since each spectrum is temporally distinct. As such, the single spectrum acquisition, combined with injection-time-aware normalization by the instrument software, preserves quantification accuracy without additional post-processing.

Improved DDA through MAP-MS

The increased dynamic range of MAP-MS spectra improves both DDA detection and quantification. To demonstrate this, we analyzed the same HeLa protein digest using identical DDA methods, except we configured precursor scans for either MAP-MS (AGC target = 1e6 charges), standard MS1s with 100% normalized AGC (AGC target = 1e6 charges), or 300% normalized AGC (AGC target = 3e6 charges). While AGC targets above 1e6 can result in increased space charging effects, researchers often configure MS1s to measure ion packets of 3e6 charges to increase sensitivity, albeit at the cost of lowered quantitative accuracy. Without modifications, the MSX AGC target in an Exploris 480 cannot be set above 1e6; therefore, we have not tested if configuring AGC higher with MAP-MS has an advantageous or detrimental effect.

As expected, across triplicate experiments, with MS-Fragger19 we detected a total of 75k peptides (5,628 protein groups) with standard MS1s configured to accumulate up to 1e6 charges, and slightly more (76k peptides, 5,747 protein groups) when configured for 3e6 charges (Fig. 4A). That improved sensitivity came at the cost of a 32% increase in %CV with IonQuant,18 indicating that quantitative reproducibility dropped (Fig. 4B). In contrast, when using MAP-MS precursors, we detected nearly 80k peptides (6,134 protein groups) producing a 9% increase in measured proteins (7% over ACG Target=3e6) while simultaneously dropping the quantitative %CV by more than half. Analysis of the detected PSMs revealed that, instead of resampling the same precursors, MAP-MS also increases peptide detection across multiple charge states (Sup. Tab. 20), thereby enhancing peptide confidence with new data.

Figure 4:

Figure 4:

(A) Number of identified protein groups (left) and peptides (right) for each acquisition method, visualized using a bar plot where each dot represents the number detected in each of three technical replicates. (B) The coefficient of variation (CV) distribution across each acquisition method as violin plots, where the median is indicated as a black dot and the box indicates the interquartile range.

Enhancing Peptide Detection in DIA through MAP-MS

While DIA is typically less dependent on precursor signals than DDA, in some cases, precursor signals are used for spectrum-centric DIA analysis23 and quantification.5 Spectrum-centric DIA analysis typically matches the elution patterns of signals in MS/MS to signals in MS1 scans to form pseudospectra.21,24 Since MAP-MS provides more accurate and more consistent low-abundance precursor signals, we hypothesized that MAP-MS DIA would improve peptide detection with search engines that utilize this approach. To test this, we used Spectronaut,25 a commonly used spectrum-centric DIA approach, to analyze 125 ng injections of a HeLa protein digest standard measured using both standard DIA (with both 1e6 and 3e6 MS1 AGC targets) and MAP-MS DIA (Fig 5A). In standard DIA runs using the library-free analysis, we detected a total of 87k peptides (6,611 protein groups) with standard MS1s configured to accumulate up to 1e6 charges, and slightly more than 95k peptides (7,208 protein groups) when configured for 3e6 charges. With MAP-MS DIA, we detected nearly 96k stripped peptide sequences (7,531 protein groups), improving overall protein detections by approximately 4% compared to 3e6 AGC Target measurements while maintaining the same quantitative precursor integration accuracy as for DDA.

Figure 5:

Figure 5:

(A) The number of identified protein groups (left) and peptides (right) for each acquisition method. Euler diagrams illustrate the overlap of protein groups and peptides identified by the three methods, with shared areas indicating those detected by multiple methods. (B) The number of unique human peptide sequences when searching MAP-MS DIA and standard DIA datasets using entrapment, where both Homo sapiens and C. elegans databases were considered. The number of misidentified entrapment peptides (red) and the percentage of entrapment false discoveries are listed.

One potential concern is that these increased detections could also increase the observed peptide False Discovery Rate (FDR). To evaluate this, we first performed an entrapment search,26 where, in addition to searching the Homo sapiens database with 4.2M tryptic peptides, 3.2M tryptic peptides from C. elegans were also considered. Since any detections of C. elegans peptides are false, we used this to assess the true rate of false discovery outside of Spectronaut (Fig. 5B). We found that even with higher reported peptides, MAP-MS DIA falsely identified fewer entrapment peptides, indicating that the increase in detections came without a meaningful penalty.

MAP-MS can also be applied to gas-phase fractionation, an effective tool for DIA library generation.27 In our study, we employed the chromatogram library generation approach,14 which generates libraries by analyzing a sample pool using six gas-phase fractions, each configured to analyze a different 100 m/z range (Fig. 6A). In the MAP-MS scheme, we adjust the MS1 measurement to inject ions from six separate 17 m/z windows. For example, the 400–500 m/z GPF-DIA MS1 analyzes the following ion packets: 399.5 – 416.5 m/z, 416.5 – 433.5 m/z, 433.5 – 450.5 m/z, 450.5 – 467.5 m/z, 467.5 – 484.5 m/z, and 484.5 – 501.5 m/z, including a small margin at the top end to capture the entire isotopic packet for each peptide in this range. As a result, MAP-MS DIA showed enhanced performance by detecting 160,076 stripped peptides across six gas-phase fractions, compared to 153,631 peptides detected with the standard DIA method. This 4.1% increase in library size was associated with improved peptide detection sensitivity.

Figure 6:

Figure 6:

(A) Schematic workflow of data acquisition and analysis. Standard DIA and MAP-MS DIA files were analyzed using either directDIA or library searching using the chromatogram library workflow. (B) Number of identified protein groups (left) and peptides (right) across acquisition methods after applying RT-based filtering. Identifications that were absent from the GPF-DIA reference or with retention time deviations greater than 90 seconds were marked as incorrect.

We found that, unsurprisingly, larger libraries help identify more peptides. With library searching, we detected 100,300 peptides and 7,856 protein groups using a MAP-MS DIA, representing a 1–3% increase over standard DIA experiments with normal chromatogram libraries (Fig. 6B). Additionally, using chromatogram libraries consistently increased detection levels compared to directDIA. While using MAP-MS did not improve the number of detected proteins as dramatically as with DDA, we did observe a consistent increase in the number of true positive peptides that match observed retention times within 90 seconds (Sup. Fig. 2). This approach represents an orthogonal method to entrapment for validating the true false discovery rate.

CONCLUSIONS:

MAP-MS is a method to extend the dynamic range of precursor spectra, enabling deeper detection rates with both DDA and DIA, as well as significantly more consistent precursor quantification. Since MAP-MS ion accumulation hides within the time it takes to acquire other scans, the approach is essentially “regret-free” and easily implementable on any current generation Thermo Orbitrap mass spectrometer with standard method development options. The approach can drop into any Orbitrap acquisition scheme (including precursor-only approaches), making it applicable to a wide range of analytes beyond peptides, including metabolites, lipids, and glycans.

While we demonstrate MAP-MS in standard proteomics experiments, increasing precursor dynamic range should have significant effects in datasets that span multiple organisms, such as metaproteomics28 and host/pathogen experiments.29 Analysis of high dynamic range biofluids,30 such as plasma, serum, and urine, should also strongly benefit from improved precursor measurements, especially for DDA. In addition, we believe MAP-MS will particularly help when match-between-runs signal inference is required for a large number of measurements, for example, with single-cell proteomics.31

Most importantly, we believe that MAP-MS shows a roadmap of how to make more sophisticated use of the ion beam during acquisition using existing hardware and software tools. In addition to raw data files, we have made the original MAP-MS Exploris method files (.meth) available at Massive (PXD054037) for rapid development and testing. While we show a method optimized for cell line experiments, other experiments may need further MPx tuning to capture lower or higher m/z species, or optimization for different ranges. For example, for phosphopeptides, Sup. Fig. S3 details the adjustment to MAP-MS windowing considering the distribution of peptide m/zs found in Phosphopedia,32 as well as the shift in ideal forbidden zone boundaries for phosphopeptides.27 Rather than wider windows, the approach can also be tuned to isolate narrow windows around specific ions in targeted experiments. We believe the new opportunities for adjusting how precursors are acquired following the general MAP-MS approach will greatly improve precursor sensitivity on Orbitraps for both general and more specialized experiments.

Supplementary Material

Supplementary Note

Supplementary Figure S1: Ion accumulation and windowing for DIA schemes.

Supplementary Figure S2: Confirmation of MAP-MS precursors by comparison to GPF-DIA.

Supplementary Figure S3: MAP-MS windows for phosphopeptides.

Supplementary Table S1: DIA precursor isolation mass list tables for MS/MS spectra

Supplementary Table S2: Precursor mass list tables for MAP-MS DDA

Supplementary Table S3: Precursor mass list tables for MAP-MS DIA

Supplementary Table S4: Mass list tables for precursor ion scan (tSIM) between 400 – 500 m/z for MAP-MS GPF-DIA

Supplementary Table S5: Mass list tables for MS/MS scan (tMS2) between 400 – 500 m/z for MAP-MS GPF-DIA and Standard GPF-DIA

Supplementary Table S6: Mass list tables for precursor ion scan (tSIM) between 500 – 600 m/z for MAP-MS GPF-DIA

Supplementary Table S7: Mass list tables for MS/MS scan (tMS2) between 500 – 600 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S8: Mass list tables for precursor ion scan (tSIM) between 600 – 700 m/z for MAP-MS GPF-DIA

Supplementary Table S9: Mass list tables for MS/MS scan (tMS2) between 600 – 700 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S10: Mass list tables for precursor ion scan (tSIM) between 700 – 800 m/z for MAP-MS GPF-DIA

Supplementary Table S11: Mass list tables for MS/MS scan (tMS2) between 700 – 800 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S12: Mass list tables for precursor ion scan (tSIM) between 800 – 900 m/z for MAP-MS GPF-DIA

Supplementary Table S13: Mass list tables for MS/MS scan (tMS2) between 800 – 900 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S14: Mass list tables for precursor ion scan (tSIM) between 900 – 1000 m/z for MAP-MS GPF-DIA

Supplementary Table S15: Mass list tables for MS/MS scan (tMS2) between 900 – 1000 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S16: Mass list tables for precursor ion scan (SIM) for Boxcar acquisition method.

Supplementary Table S17: Isolation windows for alternate MAP-MS x3 method

Supplementary Table S18: Isolation windows for alternate MAP-MS x12 method

Supplementary Table S19: Isolation windows for alternate MAP-MS x20 method

Supplementary Table S20: Number of identified peptides and their corresponding charge states detected for each acquisition method.

ACKNOWLEDGMENTS:

T.P. would like to express his deepest appreciation to H. I. Stewart, D. Chernyshev, C. Hock, E. Denisov, J.M. Garland, J. Petzoldt, A.C. Peterson, B. Hagedorn, Y. Müller, and A. Stefes at Thermo Fisher Scientific, Bremen for great mentorship. T.P. would like to express heartfelt gratitude to T. Bantersons at Roskilde University for the support and motivating influence throughout this journey.

Funding

This work is supported in part by the Pelotonia Institute for Immuno-Oncology and National Institutes of Health Grant R35-GM150723 to B.C.S.. Z.Y. was supported by the Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (grant no. 2023-RC180-03), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (grant nos. 2022-I2M-2-004, 2023-I2M-2-005, and 2021-I2M-1-061), the Natural Science Foundation of Jiangsu Province (BK20240443), the Suzhou Municipal Key Laboratory (SZS2022005), and the NCTIB Fund for the R&D Platform for Cell and Gene Therapy and is a member of the π-HuB consortium.

ABBREVIATIONS:

AGC

Automatic Gain Control

DDA

data-dependent acquisition

DIA

data-independent acquisition

GPF

gas-phase fractionation

IIT

ions injection time

LC

liquid chromatography

MAP-MS

Multiple Accumulation Precursor Mass Spectrometry

MS

mass spectrometry

ms

millisecond

OHPF

off-line moderately high-pH reversed-phase fractionation

OT

orbitrap

RT

retention time

tMS2

target MS2

tSIM

target selective ion monitoring

Footnotes

Conflict of Interest Disclosure

The Searle Lab has a sponsored research agreement with Thermo Fisher Scientific, the manufacturer of the instruments used in this research. However, the analytical methods presented here were conceptualized and implemented independently of Thermo Fisher Scientific. B.C.S. is a founder and shareholder in Proteome Software, which operates in the field of proteomics. T.P. is a participant in the Student Tech Track program at TUM Venture Labs Heilbronn.

Data availability

This study's raw mass spectrometry data have been deposited with the ProteomeXchange Consortium via the MassIVE repository. Project accession: PXD054037.

REFERENCES:

  • (1).Steen H; Mann M The ABC’s (and XYZ's) of Peptide Sequencing. Nat. Rev. Mol. Cell Biol 2004, 5 (9), 699–711. [DOI] [PubMed] [Google Scholar]
  • (2).Stahl DC; Swiderek KM; Davis MT; Lee TD Data-Controlled Automation of Liquid Chromatography/tandem Mass Spectrometry Analysis of Peptide Mixtures. J. Am. Soc. Mass Spectrom 1996, 7 (6), 532–540. [DOI] [PubMed] [Google Scholar]
  • (3).Purvine S; Eppel J-T; Yi EC; Goodlett DR Shotgun Collision-Induced Dissociation of Peptides Using a Time of Flight Mass Analyzer. Proteomics 2003, 3 (6), 847–850. [DOI] [PubMed] [Google Scholar]
  • (4).Venable JD; Dong M-Q; Wohlschlegel J; Dillin A; Yates JR Automated Approach for Quantitative Analysis of Complex Peptide Mixtures from Tandem Mass Spectra. Nat. Methods 2004, 1 (1), 39–45. [DOI] [PubMed] [Google Scholar]
  • (5).Huang T; Bruderer R; Muntel J; Xuan Y; Vitek O; Reiter L Combining Precursor and Fragment Information for Improved Detection of Differential Abundance in Data Independent Acquisition. Mol. Cell. Proteomics 2020, 19 (2), 421–430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (6).Gillet LC; Navarro P; Tate S; Röst H; Selevsek N; Reiter L; Bonner R; Aebersold R Targeted Data Extraction of the MS/MS Spectra Generated by Data-Independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis. Mol. Cell. Proteomics 2012, 11 (6), O111.016717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Meier F; Geyer PE; Virreira Winter S; Cox J; Mann M BoxCar Acquisition Method Enables Single-Shot Proteomics at a Depth of 10,000 Proteins in 100 Minutes. Nat. Methods 2018, 15 (6), 440–448. [DOI] [PubMed] [Google Scholar]
  • (8).Jenkins C; Orsburn B BoxCar Assisted MS Fragmentation (BAMF). Biochemistry, 2019. https://www.biorxiv.org/content/ 10.1101/860858v1. [DOI] [Google Scholar]
  • (9).Salovska B; Li W; Di Y; Liu Y BoxCarmax: A High-Selectivity Data-Independent Acquisition Mass Spectrometry Method for the Analysis of Protein Turnover and Complex Samples. Anal. Chem 2021, 93 (6), 3103–3111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Mehta D; Scandola S; Uhrig RG BoxCar and Library-Free Data-Independent Acquisition Substantially Improve the Depth, Range, and Completeness of Label-Free Quantitative Proteomics. Anal. Chem 2022, 94 (2), 793–802. [DOI] [PubMed] [Google Scholar]
  • (11).Egertson JD; Kuehn A; Merrihew GE; Bateman NW; MacLean BX; Ting YS; Canterbury JD; Marsh DM; Kellmann M; Zabrouskov V; Wu CC; MacCoss MJ Multiplexed MS/MS for Improved Data-Independent Acquisition. Nat. Methods 2013, 10 (8), 744–746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (12).Houel S; Abernathy R; Renganathan K; Meyer-Arendt K; Ahn NG; Old WM Quantifying the Impact of Chimera MS/MS Spectra on Peptide Identification in Large-Scale Proteomics Studies. J. Proteome Res 2010, 9 (8), 4152–4160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Amodei D; Egertson J; MacLean BX; Johnson R; Merrihew GE; Keller A; Marsh D; Vitek O; Mallick P; MacCoss MJ Improving Precursor Selectivity in Data-Independent Acquisition Using Overlapping Windows. J. Am. Soc. Mass Spectrom 2019, 30 (4), 669–684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Searle BC; Pino LK; Egertson JD; Ting YS; Lawrence RT; MacLean BX; Villén J; MacCoss MJ Chromatogram Libraries Improve Peptide Detection and Quantification by Data Independent Acquisition Mass Spectrometry. Nat. Commun 2018, 9 (1), 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Rosenberger G; Koh CC; Guo T; Röst HL; Kouvonen P; Collins BC; Heusel M; Liu Y; Caron E; Vichalkovski A; Faini M; Schubert OT; Faridi P; Ebhardt HA; Matondo M; Lam H; Bader SL; Campbell DS; Deutsch EW; Moritz RL; Tate S; Aebersold R A Repository of Assays to Quantify 10,000 Human Proteins by SWATH-MS. Sci Data 2014, 1, 140031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (16).Spahr CS; Davis MT; McGinley MD; Robinson JH; Bures EJ; Beierle J; Mort J; Courchesne PL; Chen K; Wahl RC; Yu W; Luethy R; Patterson SD Towards Defining the Urinary Proteome Using Liquid Chromatography-Tandem Mass Spectrometry. I. Profiling an Unfractionated Tryptic Digest. Proteomics 2001, 1 (1), 93–107. [DOI] [PubMed] [Google Scholar]
  • (17).Panchaud A; Scherl A; Shaffer SA; von Haller PD; Kulasekara HD; Miller SI; Goodlett DR Precursor Acquisition Independent from Ion Count: How to Dive Deeper into the Proteomics Ocean. Anal. Chem 2009, 81 (15), 6481–6488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).Yu F; Haynes SE; Nesvizhskii AI IonQuant Enables Accurate and Sensitive Label-Free Quantification With FDR-Controlled Match-Between-Runs. Mol. Cell. Proteomics 2021, 20. 10.1016/j.mcpro.2021.100077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Kong AT; Leprevost FV; Avtonomov DM; Mellacheruvu D; Nesvizhskii AI MSFragger: Ultrafast and Comprehensive Peptide Identification in Mass Spectrometry–based Proteomics. Nat. Methods 2017, 14 (5), 513–520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (20).Yu F; Deng Y; Nesvizhskii AI MSFragger-DDA+ Enhances Peptide Identification Sensitivity with Full Isolation Window Search. Nat. Commun 2025, 16 (1), 3329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Tsou C-C; Avtonomov D; Larsen B; Tucholska M; Choi H; Gingras A-C; Nesvizhskii AI DIA-Umpire: Comprehensive Computational Framework for Data-Independent Acquisition Proteomics. Nat. Methods 2015, 12 (3), 258–264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (22).Bruce JE; Anderson GA; Wen J; Harkewicz R; Smith RD High-Mass-Measurement Accuracy and 100% Sequence Coverage of Enzymatically Digested Bovine Serum Albumin from an ESI-FTICR Mass Spectrum. Anal. Chem 1999, 71 (14), 2595–2599. [DOI] [PubMed] [Google Scholar]
  • (23).Ting YS; Egertson JD; Payne SH; Kim S; MacLean B; Käll L; Aebersold R; Smith RD; Noble WS; MacCoss MJ Peptide-Centric Proteome Analysis: An Alternative Strategy for the Analysis of Tandem Mass Spectrometry Data. Mol. Cell. Proteomics 2015, 14 (9), 2301–2307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (24).Geromanos SJ; Vissers JPC; Silva JC; Dorschel CA; Li G-Z; Gorenstein MV; Bateman RH; Langridge JI The Detection, Correlation, and Comparison of Peptide Precursor and Product Ions from Data Independent LC-MS with Data Dependant LC-MS/MS. Proteomics 2009, 9 (6), 1683–1695. [DOI] [PubMed] [Google Scholar]
  • (25).Bruderer R; Bernhardt OM; Gandhi T; Miladinović SM; Cheng L-Y; Messner S; Ehrenberger T; Zanotelli V; Butscheid Y; Escher C; Vitek O; Rinner O; Reiter L Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues. Mol. Cell. Proteomics 2015, 14 (5), 1400–1410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (26).Feng X-D; Li L-W; Zhang J-H; Zhu Y-P; Chang C; Shu K-X; Ma J Using the Entrapment Sequence Method as a Standard to Evaluate Key Steps of Proteomics Data Analysis Process. BMC Genomics 2017, 18 (Suppl 2), 143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (27).Pino LK; Just SC; MacCoss MJ; Searle BC Acquiring and Analyzing Data Independent Acquisition Proteomics Experiments without Spectrum Libraries. Mol. Cell. Proteomics 2020. 10.1074/mcp.P119.001913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (28).Saito MA; Bertrand EM; Duffy ME; Gaylord DA; Held NA; Hervey WJ 4th; Hettich RL; Jagtap PD; Janech MG; Kinkade DB; Leary DH; McIlvin MR; Moore EK; Morris RM; Neely BA; Nunn BL; Saunders JK; Shepherd AI; Symmonds NI; Walsh DA Progress and Challenges in Ocean Metaproteomics and Proposed Best Practices for Data Sharing. J. Proteome Res 2019, 18 (4), 1461–1476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (29).Jean Beltran PM; Federspiel JD; Sheng X; Cristea IM Proteomics and Integrative Omic Approaches for Understanding Host-Pathogen Interactions and Infectious Diseases. Mol. Syst. Biol 2017, 13 (3), 922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (30).Anderson NL; Anderson NG The Human Plasma Proteome: History, Character, and Diagnostic Prospects. Mol. Cell. Proteomics 2002, 1 (11), 845–867. [DOI] [PubMed] [Google Scholar]
  • (31).Ghosh G; Shannon AE; Searle BC Data Acquisition Approaches for Single Cell Proteomics. Proteomics 2025, 25 (1–2), e2400022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (32).Lawrence RT; Searle BC; Llovet A; Villén J Plug-and-Play Analysis of the Human Phosphoproteome by Targeted High-Resolution Mass Spectrometry. Nat. Methods 2016, 13 (5), 431–434. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Note

Supplementary Figure S1: Ion accumulation and windowing for DIA schemes.

Supplementary Figure S2: Confirmation of MAP-MS precursors by comparison to GPF-DIA.

Supplementary Figure S3: MAP-MS windows for phosphopeptides.

Supplementary Table S1: DIA precursor isolation mass list tables for MS/MS spectra

Supplementary Table S2: Precursor mass list tables for MAP-MS DDA

Supplementary Table S3: Precursor mass list tables for MAP-MS DIA

Supplementary Table S4: Mass list tables for precursor ion scan (tSIM) between 400 – 500 m/z for MAP-MS GPF-DIA

Supplementary Table S5: Mass list tables for MS/MS scan (tMS2) between 400 – 500 m/z for MAP-MS GPF-DIA and Standard GPF-DIA

Supplementary Table S6: Mass list tables for precursor ion scan (tSIM) between 500 – 600 m/z for MAP-MS GPF-DIA

Supplementary Table S7: Mass list tables for MS/MS scan (tMS2) between 500 – 600 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S8: Mass list tables for precursor ion scan (tSIM) between 600 – 700 m/z for MAP-MS GPF-DIA

Supplementary Table S9: Mass list tables for MS/MS scan (tMS2) between 600 – 700 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S10: Mass list tables for precursor ion scan (tSIM) between 700 – 800 m/z for MAP-MS GPF-DIA

Supplementary Table S11: Mass list tables for MS/MS scan (tMS2) between 700 – 800 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S12: Mass list tables for precursor ion scan (tSIM) between 800 – 900 m/z for MAP-MS GPF-DIA

Supplementary Table S13: Mass list tables for MS/MS scan (tMS2) between 800 – 900 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S14: Mass list tables for precursor ion scan (tSIM) between 900 – 1000 m/z for MAP-MS GPF-DIA

Supplementary Table S15: Mass list tables for MS/MS scan (tMS2) between 900 – 1000 m/z for MAP-MS GPF-DIA and standard GPF-DIA

Supplementary Table S16: Mass list tables for precursor ion scan (SIM) for Boxcar acquisition method.

Supplementary Table S17: Isolation windows for alternate MAP-MS x3 method

Supplementary Table S18: Isolation windows for alternate MAP-MS x12 method

Supplementary Table S19: Isolation windows for alternate MAP-MS x20 method

Supplementary Table S20: Number of identified peptides and their corresponding charge states detected for each acquisition method.

Data Availability Statement

This study's raw mass spectrometry data have been deposited with the ProteomeXchange Consortium via the MassIVE repository. Project accession: PXD054037.

RESOURCES